Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
about
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Cerebrospinal fluid levels of ...... n levodopa-induced dyskinesia.
@en
type
label
Cerebrospinal fluid levels of ...... n levodopa-induced dyskinesia.
@en
prefLabel
Cerebrospinal fluid levels of ...... n levodopa-induced dyskinesia.
@en
P2093
P2860
P50
P921
P356
P1476
Cerebrospinal fluid levels of ...... n levodopa-induced dyskinesia.
@en
P2093
Akram Kamal
Helle Thagesen
Jan Bert Paul Gramsbergen
Troels Wesenberg Kjaer
P2860
P304
P356
10.1111/JNC.13997
P407
P577
2017-02-28T00:00:00Z